J F Todd1, K Meeran. Show Affiliations » 1. Endocrine Unit, Hammersmith Hospital, Imperial College of Science, Technology and Medicine, London, UK.
Abstract
Entities: Disease
Mesh： See more » Antineoplastic Agents, Hormonal/metabolismAntineoplastic Agents, Hormonal/therapeutic useCarcinoid Tumor/drug therapyCarcinoid Tumor/metabolismCarcinoid Tumor/secondaryDelayed-Action PreparationsFemaleHumansIleal Neoplasms/drug therapyIleal Neoplasms/metabolismIleal Neoplasms/surgeryLiver Neoplasms/drug therapyLiver Neoplasms/metabolismLiver Neoplasms/secondaryOctreotide/metabolismOctreotide/therapeutic usePeptides, Cyclic/therapeutic useReceptors, Somatostatin/metabolismSomatostatin/analogs & derivativesSomatostatin/therapeutic use
Substances： See more » Antineoplastic Agents, HormonalDelayed-Action PreparationsPeptides, CyclicReceptors, SomatostatinlanreotideSomatostatinOctreotide
Year: 2000 PMID： 11155085 DOI： 10.1046/j.1365-2265.2000.01109.x
Source DB: PubMed Journal: Clin Endocrinol (Oxf) ISSN： 0300-0664 Impact factor: 3.478